# Antibiotics-Induced Gut Microbiome Dysbiosis Affects Susceptibility to Minus Lens-Induced Myopia in Mice

**Authors:** Shin-ichi Ikeda, Deokho Lee, Junhan Chen, Shinji Fukuda, Kazuno Negishi, Kazuo Tsubota, Toshihide Kurihara

PMC · DOI: 10.1167/iovs.66.6.76 · 2025-06-25

## TL;DR

This study shows that antibiotics affecting gut bacteria can influence myopia development in mice, suggesting a link between gut health and eye health.

## Contribution

The study reveals a novel connection between gut microbiome dysbiosis and myopia susceptibility in mice.

## Key findings

- Vancomycin, neomycin, and a mix of antibiotics made mice resistant to lens-induced myopia.
- Clostridiaceae abundance increased in mice resistant to myopia.
- Antibiotic-induced gut dysbiosis may influence myopia development.

## Abstract

The prevalence of myopia has increased worldwide in recent decades, shifting the focus in research from genetic to environmental factors. The roles of diet in the development of myopia may be directly associated with gut microbiota composition. Therefore this study evaluated the effects of antibiotic-induced gut dysbiosis on the development of negative lens-induced myopia.

We administered several antibiotics (ampicillin, vancomycin, neomycin, or a mixture) to induce gut dysbiosis in male C57BL/6J mice with negative lens-induced myopia. Gut microbiome profiles were analyzed by 16 S rRNA gene sequencing.

Mice administered vancomycin, neomycin, and a mixture of three antibiotics exhibited resistance to lens-induced myopia, unlike control or ampicillin-administered mice. Further analyses revealed no specific trend in the gut microbiota composition and diversity related to myopia resistance, except for an increase in the abundance of Clostridiaceae.

These findings demonstrate the potential role of the gut microbiome, particularly Clostridiaceae family, in myopia susceptibility. This study offers new insights into the preventive strategies and therapeutic interventions to mitigate myopia development.

## Linked entities

- **Chemicals:** ampicillin (PubChem CID 6249), vancomycin (PubChem CID 14969), neomycin (PubChem CID 8378)
- **Diseases:** myopia (MONDO:0001384)

## Full-text entities

- **Diseases:** Myopia (MESH:D009216), Microbiome Dysbiosis (MESH:D064806)
- **Chemicals:** Minus Lens (-), vancomycin (MESH:D014640), neomycin (MESH:D009355), ampicillin (MESH:D000667)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], gut metagenome (species) [taxon 749906]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12205566/full.md

---
Source: https://tomesphere.com/paper/PMC12205566